Deal snapshot: Qiagen Acquires Majority Stake in Polish Enzymes Provider Blirt.

MANews-(C)2009-2022

German sample and assays technology provider Qiagen N.V. (NYSE: QGEN) (Frankfurt Prime Standard: QIA) has signed agreements to acquire a 96% majority ownership stake in Poland-based recombinant enzymes manufacturer Blirt SA (Polish Stock Exchange: BLR), the company said.

Blirt develops, manufactures and commercializes standardized and customized solutions for proteins and enzymes as well...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT